title: A role for the integrin alphavbeta8 in the negative regulation of epithelial cell growth.
abstract: The control of cell growth is regulated through coordinated responses to growth factors and cell-extracellular matrix (ECM) interactions. Integrins, the major family of cell-ECM receptors, are vital to these coordinated responses. Although much is known of the role of integrins in growth promotion, specific examples of integrin-mediated cell growth inhibition are few. On the basis of our findings that the integrin beta8 subunit is expressed in airway epithelial cells and is absent in lung cancers, we investigated the role and mechanism of the integrin alphavbeta8 in mediating growth inhibition. When introduced into either a lung or colon carcinoma cell line, beta8 inhibited cell growth without inducing apoptosis. Ligation of alphavbeta8 also induced cell rounding, inhibited focal contact formation, and initiated an inhibitory signaling pathway as demonstrated by increased expression of the cyclin-dependent kinase inhibitor p21Cip1. The cytoplasmic domain of beta8 was capable of both growth inhibition and causing cell shape changes as shown by the use of a chimeric integrin construct consisting of the beta8-cytoplasmic domain coupled to the beta6-extracellular domain. Finally, when tested in vivo, beta8 potently inhibited tumor growth in nude mice. Together, these results implicate alphavbeta8 as a novel growth-regulatory molecule of epithelial cells.
authors.affiliation: Department of Anatomic Pathology, University of California at San Francisco, 94143, USA.
authors.forename: S
authors.initials: S
authors.lastname: Cambier
authors.forename: D Z
authors.initials: DZ
authors.lastname: Mu
authors.forename: D
authors.initials: D
authors.lastname: O'Connell
authors.forename: K
authors.initials: K
authors.lastname: Boylen
authors.forename: W
authors.initials: W
authors.lastname: Travis
authors.forename: W H
authors.initials: WH
authors.lastname: Liu
authors.forename: V C
authors.initials: VC
authors.lastname: Broaddus
authors.forename: S L
authors.initials: SL
authors.lastname: Nishimura
mesh_terms: D000199:Actins / Q000378:metabolism; D000818:Animals; D017209:Apoptosis; D015153:Blotting, Western; D002448:Cell Adhesion; D002455:Cell Division; D002469:Cell Separation; D003110:Colonic Neoplasms / Q000378:metabolism; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins / Q000378:metabolism; D003593:Cytoplasm / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004847:Epithelial Cells / Q000166:cytology*; D005109:Extracellular Matrix / Q000378:metabolism; D005434:Flow Cytometry; D006801:Humans; D007150:Immunohistochemistry; D016023:Integrins / Q000502:physiology*; D008175:Lung Neoplasms / Q000378:metabolism; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D011233:Precipitin Tests; D017434:Protein Structure, Tertiary; D012190:Retroviridae / Q000235:genetics; D014161:Transduction, Genetic; D014407:Tumor Cells, Cultured; D016596:Vinculin / Q000378:metabolism
chemical_list: D000199:Actins; C493956:CDKN1A protein, human; C493957:Cdkn1a protein, mouse; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins; D016023:Integrins; C403414:integrin alphavbeta8; D016596:Vinculin